Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
peripheral arterial disease [dsyn]
Initiative [menp]
Observational Study [resa]
Reported [inpr]
Carotid Atherosclerosis [dsyn]
Health [idcn]
Women [popg]
Take [hlca]
postmenopausal [tmco]
Hormone Therapy [topp]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
Peripheral [spco]
Arterial [bpoc]
Events [evnt]
Women [popg]
Pre-existing [qlco]
coronary heart disease [dsyn]
Evaluate [ftcn]
peripheral arterial disease [dsyn]
Health [idcn]
Women [popg]
Initiative [menp]
randomized [resa]
Trial [resa]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Methods [inpr]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Trial [resa]
Assigned [ftcn]
postmenopausal [tmco]
Women [popg]
Age-Years [tmco]
Daily [tmco]
Estrogens, Conjugated [horm, phsu, strd]
mg% [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
2 5 [qnco]
mg% [qnco]
placebo [topp]
Documented [hlca]
Health Outcomes [inpr]
Average [qnco]
5 6 [fndg]
Hospitalization [hlca]
peripheral arterial disease [dsyn]
Infrequent [tmco]
carotid disease [dsyn]
Lower Extremity [blor]
Arterial disease [dsyn]
Aortic Aneurysm, Abdominal [dsyn]
Peripheral [spco]
Arterial [bpoc]
Events [evnt]
treatment [ftcn]
Group [idcn]
Hazard Ratio [qnco]
Slightly [idcn]
Women [popg]
Assigned [ftcn]
Active [ftcn]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
Hazard Ratio [qnco]
Hazard Ratio [qnco]
Slightly [idcn]
Late [tmco]
Hazard Ratio [qnco]
Equal [qlco]
adherent [ftcn]
participants [popg]
Hazard Ratio [qnco]
Peripheral [spco]
Arterial [bpoc]
Events [evnt]
5 6 [fndg]
subgroup [virs]
Identified [qlco]
Interaction [ftcn]
Estrogen [horm, phsu, strd]
Progestin [horm, phsu, strd]
baseline [bodm]
Characteristics [qlco]
peripheral arterial disease [dsyn]
Conclusions [idcn]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Estrogens, Conjugated [horm, phsu, strd]
Progestin [horm, phsu, strd]
Protection [fndg]
peripheral arterial disease [dsyn]
